-
公开(公告)号:US20210386689A1
公开(公告)日:2021-12-16
申请号:US17286155
申请日:2019-10-30
Applicant: Sunovion Pharmaceuticals Inc.
Inventor: Jing LIN
IPC: A61K31/135 , A61K31/137 , A61K31/536 , A61K31/55 , A61K31/496 , A61K31/427
Abstract: Provided herein are methods of treating central nervous system (CNS) disorders (e.g., Binge Eating Disorder (BED), Attention-Deficit/Hyperactivity Disorder (ADHD), etc.) with a dasotraline therapy while avoiding adverse drug interactions.